This reduction was corroborated by the publicly available AD patient astrocyte transcriptomic dataset (Supplementary Fig. 13c) and protein analysis in AD mice (Supplementary Fig. 13d), highlighting astrocytic Hbβ as a potential therapeutic target. The gene discussed is HBB; the disease is Alzheimer disease.